Connect with us:
CURRENT ISSUE
February 2025
February 2025
Jennifer Lotter, PA-C
PA Lotter discusses the "scope creep" debate between the American Medical Association (AMA) and the American Association of Physician Associates (AAPA) and how the campaign has negatviely affected advanced practitioners and other non-physician providers.
February 2025
A new clinical trial combining lower-intensity CPX-351 therapy plus venetoclax as induction therapy has shown positive initial results among patients with acute myeloid leukemia (AML) who are deemed unfit for intensive chemotherapy.
February 2025
C-reactive protein (CRP) levels may help identify patients on immune checkpoint inhibitors (ICIs) who are at increased risk of venous thromboembolism (VTE).
February 2025
Measurable residual disease (MRD)-negative complete response was the most relevant prognostic factor identified among patients with relapsed or refractory multiple myeloma (R/R MM) treated with T-cell redirecting immunotherapy.
